130 related articles for article (PubMed ID: 38041812)
1. De novo NAD
Wan J; Cheng C; Hu J; Huang H; Han Q; Jie Z; Zou Q; Shi JH; Yu X
Cell Rep; 2023 Dec; 42(12):113518. PubMed ID: 38041812
[TBL] [Abstract][Full Text] [Related]
2. Macrophage de novo NAD
Minhas PS; Liu L; Moon PK; Joshi AU; Dove C; Mhatre S; Contrepois K; Wang Q; Lee BA; Coronado M; Bernstein D; Snyder MP; Migaud M; Majeti R; Mochly-Rosen D; Rabinowitz JD; Andreasson KI
Nat Immunol; 2019 Jan; 20(1):50-63. PubMed ID: 30478397
[TBL] [Abstract][Full Text] [Related]
3. SENP7 senses oxidative stress to sustain metabolic fitness and antitumor functions of CD8+ T cells.
Wu Z; Huang H; Han Q; Hu Z; Teng XL; Ding R; Ye Y; Yu X; Zhao R; Wang Z; Zou Q
J Clin Invest; 2022 Apr; 132(7):. PubMed ID: 35143421
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Rewiring of Kynurenine Pathway during Hepatic Ischemia-Reperfusion Injury Exacerbates Liver Damage by Impairing NAD Homeostasis.
Xu B; Zhang P; Tang X; Wang S; Shen J; Zheng Y; Gao C; Mi P; Zhang C; Qu H; Li S; Yuan D
Adv Sci (Weinh); 2022 Dec; 9(35):e2204697. PubMed ID: 36310151
[TBL] [Abstract][Full Text] [Related]
5. Effects of Kynurenine Pathway Inhibition on NAD Metabolism and Cell Viability in Human Primary Astrocytes and Neurons.
Braidy N; Guillemin GJ; Grant R
Int J Tryptophan Res; 2011; 4():29-37. PubMed ID: 22084601
[TBL] [Abstract][Full Text] [Related]
6. Kynurenine pathway, NAD
Castro-Portuguez R; Sutphin GL
Exp Gerontol; 2020 Apr; 132():110841. PubMed ID: 31954874
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the kynurenine pathway in skin-derived fibroblasts and keratinocytes.
Sheipouri D; Grant R; Bustamante S; Lovejoy D; Guillemin GJ; Braidy N
J Cell Biochem; 2015 Jun; 116(6):903-22. PubMed ID: 25639585
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis induced in C57BL/6 mice by a non-ß oxidizable fatty acid analogue is associated with reduced plasma kynurenine metabolites and a modified hepatic NAD
Berge RK; Cacabelos D; Señarís R; Nordrehaug JE; Nygård O; Skorve J; Bjørndal B
Lipids Health Dis; 2020 May; 19(1):94. PubMed ID: 32410680
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Kynurenine and NAD
Wnorowski A; Wnorowska S; Kurzepa J; Parada-Turska J
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948292
[TBL] [Abstract][Full Text] [Related]
10. Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer.
Liu HY; Wang FH; Liang JM; Xiang YY; Liu SH; Zhang SW; Zhu CM; He YL; Zhang CH
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2743-2756. PubMed ID: 35776198
[TBL] [Abstract][Full Text] [Related]
11. Acylglycerol Kinase Maintains Metabolic State and Immune Responses of CD8
Hu Z; Qu G; Yu X; Jiang H; Teng XL; Ding L; Hu Q; Guo X; Zhou Y; Wang F; Li HB; Chen L; Jiang J; Su B; Liu J; Zou Q
Cell Metab; 2019 Aug; 30(2):290-302.e5. PubMed ID: 31204281
[TBL] [Abstract][Full Text] [Related]
12. Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B.
Montali I; Ceccatelli Berti C; Morselli M; Acerbi G; Barili V; Pedrazzi G; Montanini B; Boni C; Alfieri A; Pesci M; Loglio A; Degasperi E; Borghi M; Perbellini R; Penna A; Laccabue D; Rossi M; Vecchi A; Tiezzi C; Reverberi V; Boarini C; Abbati G; Massari M; Lampertico P; Missale G; Ferrari C; Fisicaro P
J Hepatol; 2023 Jul; 79(1):50-60. PubMed ID: 36893853
[TBL] [Abstract][Full Text] [Related]
13. Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.
Braidy N; Berg J; Clement J; Khorshidi F; Poljak A; Jayasena T; Grant R; Sachdev P
Antioxid Redox Signal; 2019 Jan; 30(2):251-294. PubMed ID: 29634344
[No Abstract] [Full Text] [Related]
14. Inhibition of indoleamine 2,3-dioxygenase activity in IFN-gamma stimulated astroglioma cells decreases intracellular NAD levels.
Grant R; Kapoor V
Biochem Pharmacol; 2003 Sep; 66(6):1033-6. PubMed ID: 12963490
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine Pathway Metabolism is Involved in the Maintenance of the Intracellular NAD Concentration in Human Primary Astrocytes.
Grant R; Nguyen S; Guillemin G
Int J Tryptophan Res; 2010; 3():151-6. PubMed ID: 22084595
[TBL] [Abstract][Full Text] [Related]
16. NAD
Groth B; Venkatakrishnan P; Lin SJ
Front Mol Biosci; 2021; 8():686412. PubMed ID: 34095234
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Control of CD8
Zhang L; Romero P
Trends Mol Med; 2018 Jan; 24(1):30-48. PubMed ID: 29246759
[TBL] [Abstract][Full Text] [Related]
18. The kynurenine pathway in brain tumor pathogenesis.
Adams S; Braidy N; Bessede A; Brew BJ; Grant R; Teo C; Guillemin GJ
Cancer Res; 2012 Nov; 72(22):5649-57. PubMed ID: 23144293
[TBL] [Abstract][Full Text] [Related]
19. Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD
Moffett JR; Arun P; Puthillathu N; Vengilote R; Ives JA; Badawy AA; Namboodiri AM
Front Immunol; 2020; 11():31. PubMed ID: 32153556
[TBL] [Abstract][Full Text] [Related]
20. Damage-induced NAD release activates intestinal CD4+ and CD8+ T cell via P2X7R signaling.
Bu F; Huang S; Yang X; Wei L; Zhang D; Zhang Z; Tian D
Cell Immunol; 2023 Mar; 385():104677. PubMed ID: 36746070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
